T1	PROC 90 110	estudio de extensión
T2	DISO 114 118	gota
#1	AnnotatorNotes T2	C0018099; Gout; Disease or Syndrome
T3	PROC 141 161	Estudio de extensión
T4	CHEM 208 218	alopurinol
#2	AnnotatorNotes T4	C0002144; allopurinol; Organic Chemical · Pharmacologic Substance
T5	PROC 255 286	estudio de eficacia y seguridad
T6	CHEM 302 312	alopurinol
#3	AnnotatorNotes T6	C0002144; allopurinol; Organic Chemical · Pharmacologic Substance
T7	DISO 336 340	Gota
#4	AnnotatorNotes T7	C0018099; Gout; Disease or Syndrome
T8	PROC 413 427	procedimientos
#5	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T9	PROC 491 527	consentimiento informado por escrito
#6	AnnotatorNotes T9	C0811741; Obtain informed written consent; Health Care Activity
T10	PROC 648 671	tratamiento doble ciego
T11	CHEM 179 188	lesinurad
#7	AnnotatorNotes T11	C3886073; lesinurad; Organic Chemical · Pharmacologic Substance
T12	CHEM 769 779	medicación
#8	AnnotatorNotes T12	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T13	CHEM 290 299	lesinurad
#9	AnnotatorNotes T13	C3886073; lesinurad; Organic Chemical · Pharmacologic Substance
T14	PROC 805 812	placebo
#10	AnnotatorNotes T14	C0032042; Placebos; Therapeutic or Preventive Procedure
T15	CHEM 816 826	alopurinol
#11	AnnotatorNotes T15	C0002144; allopurinol; Organic Chemical · Pharmacologic Substance
T16	PROC 911 920	protocolo
#12	AnnotatorNotes T16	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T17	PROC 1025 1058	método anticonceptivo no hormonal
T18	CHEM 1050 1058	hormonal
#13	AnnotatorNotes T18	C0019932; Hormones; Hormone
T19	CHEM 1147 1157	medicación
#14	AnnotatorNotes T19	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T20	DISO 1230 1259	afección médica o psicológica
T21	PROC 1449 1458	protocolo
#15	AnnotatorNotes T21	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T22	CHEM 61 70	lesinurad
#16	AnnotatorNotes T22	C3886073; lesinurad; Organic Chemical · Pharmacologic Substance
T23	CHEM 73 83	alopurinol
#17	AnnotatorNotes T23	C0002144; allopurinol; Organic Chemical · Pharmacologic Substance
T24	CHEM 793 802	lesinurad
#18	AnnotatorNotes T24	C3886073; lesinurad; Organic Chemical · Pharmacologic Substance
T25	Date 13 17	2012
T26	Date 162 175	a largo plazo
T27	LIVB 228 237	pacientes
#19	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	LIVB 372 380	paciente
#20	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T30	LIVB 611 619	paciente
#21	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Date 844 850	mes 12
T32	LIVB 857 865	paciente
#22	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T33	LIVB 927 935	paciente
#23	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	LIVB 939 945	hombre
#24	AnnotatorNotes T34	C0025266; Male population group; Population Group
T35	LIVB 948 953	mujer
#25	AnnotatorNotes T35	C0043210; Woman; Population Group
T36	LIVB 959 966	mujeres
#26	AnnotatorNotes T36	C0043210; Woman; Population Group
T37	Neg_cue 1047 1049	no
T38	Duration 1097 1113	al menos 14 días
T39	CONC 1128 1140	última dosis
T40	LIVB 1202 1210	paciente
#27	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	LIVB 1278 1290	investigador
#28	AnnotatorNotes T41	C0035173; Research Personnel; Professional or Occupational Group
T42	LIVB 1299 1313	monitor médico
#29	AnnotatorNotes T42	C1708968; Medical Monitor; Professional or Occupational Group
T44	LIVB 1361 1369	paciente
#30	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	LIVB 1404 1412	paciente
#31	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	PHYS 971 1002	capacidad de quedar embarazadas
#32	AnnotatorNotes T46	C3831118; Childbearing Potential; Clinical Attribute
T47	PHYS 400 408	entender
#33	AnnotatorNotes T47	C0162340; Comprehension; Mental Process
T29	PROC 899 906	visitas
#34	AnnotatorNotes T29	C1512346; Patient Visit; Health Care Activity
T43	PROC 833 839	visita
#35	AnnotatorNotes T43	C1512346; Patient Visit; Health Care Activity
A1	Assertion T18 Negated
#36	AnnotatorNotes T5	C0511730; Identify product efficacy and safety issues; Health Care Activity
#37	AnnotatorNotes T10	C0013072; Double-Blind Method; Research Activity
T48	Spec_cue 1315 1321	podría
T49	Observation 1334 1340	riesgo
A2	Assertion T49 Speculated
T50	Quantifier_or_Qualifier 1341 1352	innecesario
A3	Assertion T50 Speculated
T51	CONC 1372 1382	interferir
A4	Assertion T51 Speculated
#38	AnnotatorNotes T51	C0521102; Interferes with; Functional Concept
R1	Speculation Arg1:T48 Arg2:T49	
R2	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T50	
R3	Speculation Arg1:T48 Arg2:T51	
R4	Combined_with Arg1:T22 Arg2:T23	
R5	Overlap Arg1:T3 Arg2:T26	
R6	Combined_with Arg1:T11 Arg2:T4	
R7	Experiences Arg1:T27 Arg2:T11	
R8	Experiences Arg1:T27 Arg2:T13	
R9	Combined_with Arg1:T13 Arg2:T6	
R10	Before Arg1:T5 Arg2:T3	
T52	Observation 387 396	capacidad
#39	AnnotatorNotes T52	C1299581; Able (finding); Finding (?) | C1555472; Authorized; Finding (?)
R12	Experiences Arg1:T28 Arg2:T47	
R13	Overlap Arg1:T47 Arg2:T8	
T53	Observation 474 487	desea otorgar
#40	AnnotatorNotes T53	C0600109; Willin; Finding (?)
R14	Overlap Arg1:T53 Arg2:T9	
R16	Before Arg1:T9 Arg2:T8	
T54	Observation 453 460	riesgos
R17	Experiences Arg1:T28 Arg2:T54	
R18	Causes Arg1:T8 Arg2:T54	
T55	PROC 597 604	estudio
#41	AnnotatorNotes T55	C0008976; Clinical Trials; Research Activity
R19	Before Arg1:T9 Arg2:T55	
T56	Observation 623 671	completado el periodo de tratamiento doble ciego
R21	Experiences Arg1:T30 Arg2:T10	
T57	Observation 756 765	tolerando
R22	Experiences Arg1:T30 Arg2:T57	
R23	Overlap Arg1:T57 Arg2:T12	
R24	Experiences Arg1:T30 Arg2:T12	
R25	Overlap Arg1:T57 Arg2:T24	
R26	Experiences Arg1:T30 Arg2:T14	
R27	Overlap Arg1:T57 Arg2:T14	
R28	Used_for Arg1:T12 Arg2:T10	
R29	Used_for Arg1:T24 Arg2:T10	
R31	Used_for Arg1:T15 Arg2:T10	
R32	Experiences Arg1:T30 Arg2:T15	
R33	Overlap Arg1:T57 Arg2:T15	
R34	Overlap Arg1:T15 Arg2:T43	
R35	Overlap Arg1:T14 Arg2:T43	
R36	Overlap Arg1:T24 Arg2:T43	
R37	Overlap Arg1:T12 Arg2:T43	
R38	Overlap Arg1:T57 Arg2:T43	
R39	Overlap Arg1:T43 Arg2:T31	
R40	Experiences Arg1:T30 Arg2:T24	
T58	Observation 866 881	desea adherirse
#42	AnnotatorNotes T58	C0600109; Willing; Finding (?)
R41	Experiences Arg1:T32 Arg2:T29	
R42	Overlap Arg1:T58 Arg2:T29	
R43	Overlap Arg1:T58 Arg2:T16	
R44	Experiences Arg1:T36 Arg2:T46	
R45	Experiences Arg1:T35 Arg2:T46	
R46	Experiences Arg1:T36 Arg2:T17	
R47	Negation Arg1:T37 Arg2:T18	
R48	Used_for Arg1:T18 Arg2:T17	
R49	Experiences Arg1:T35 Arg2:T17	
T59	Quantifier_or_Qualifier 1059 1067	efectivo
R50	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T59	
R51	Has_Duration_or_Interval Arg1:T17 Arg2:T38	
T60	PROC 1079 1086	estudio
#43	AnnotatorNotes T60	C0008976; Clinical Trials; Research Activity
R52	Overlap Arg1:T17 Arg2:T60	
R53	Overlap Arg1:T46 Arg2:T60	
R54	Overlap Arg1:T46 Arg2:T17	
R55	After Arg1:T17 Arg2:T39	
R56	Has_Dose_or_Strength Arg1:T19 Arg2:T39	
R57	Experiences Arg1:T33 Arg2:T46	
R58	Experiences Arg1:T33 Arg2:T17	
R59	Experiences Arg1:T33 Arg2:T19	
R60	Experiences Arg1:T35 Arg2:T19	
R61	Experiences Arg1:T36 Arg2:T19	
R62	Experiences Arg1:T40 Arg2:T20	
R63	Before Arg1:T20 Arg2:T49	
R65	Experiences Arg1:T44 Arg2:T20	
R66	Experiences Arg1:T44 Arg2:T49	
R67	Experiences Arg1:T40 Arg2:T49	
T61	Observation 1418 1458	cumplir con los requisitos del protocolo
#44	AnnotatorNotes T61	C0582783; Ability to comply with treatment; Finding (?)
T62	Observation 1466 1486	completar el estudio
#45	AnnotatorNotes T62	C2732579; Completion of clinical trial; Finding
R72	Before Arg1:T61 Arg2:T62	
R73	Overlap Arg1:T49 Arg2:T61	
R74	Experiences Arg1:T45 Arg2:T49	
R77	Experiences Arg1:T45 Arg2:T20	
R78	Overlap Arg1:T52 Arg2:T47	
R79	Experiences Arg1:T28 Arg2:T8	
R80	Overlap Arg1:T10 Arg2:T57	
#46	AnnotatorNotes T54	C0559571; At risk; Finding
#47	AnnotatorNotes T49	C0559571; At risk; Finding
R11	Experiences Arg1:T30 Arg2:T43	
#48	AnnotatorNotes T59	C1704419; Effective; Qualitative Concept
#49	AnnotatorNotes R56	(?)
#50	AnnotatorNotes T39	C1762893; Date last dose; Temporal Concept
#51	AnnotatorNotes T26	C0443252; Long-term; Temporal Concept
#52	AnnotatorNotes T20	C0221423; Illness (finding); Sign or Symptom | C0849888; psychological disturbance; Mental or Behavioral Dysfunction (?)
A5	Experiencer T27 Patient
A6	Experiencer T28 Patient
A7	Experiencer T30 Patient
A8	Experiencer T32 Patient
A9	Experiencer T33 Patient
A10	Experiencer T34 Patient
A11	Experiencer T35 Patient
A12	Experiencer T36 Patient
A13	Experiencer T40 Patient
A14	Experiencer T41 Other
A15	Experiencer T42 Other
A16	Experiencer T44 Patient
A17	Experiencer T45 Patient
